Averting HIV Infections in New York City: A Modeling Approach Estimating the Future Impact of Additional Behavioral and Biomedical HIV Prevention Strategies

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Kessler, Jason ^a   Myers, Julie E ^b,c   Nucifora, Kimberly A ^a   Mensah, Nana ^b   Kowalski, Alexis ^a   Sweeney, Monica ^b   Toohey, Christopher ^a   Khademi, Amin ^d   Shepard, Colin ^b   Cutler, Blayne ^b   Braithwaite, R Scott ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d University of Pittsburgh   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; CD4 LYMPHOCYTE COUNT; CONDOM USE; COST CONTROL; DISEASE COURSE; DISEASE MODEL; EPIDEMIC; FEMALE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH PROGRAM; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MALE; POST EXPOSURE PROPHYLAXIS; PUBLIC HEALTH SERVICE; RISK REDUCTION; UNITED STATES; VIRUS LOAD; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; CONDOMS; COST-BENEFIT ANALYSIS; EPIDEMICS; EPIDEMIOLOGICAL MONITORING; FEMALE; FORECASTING; HEALTH CARE COSTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEW YORK CITY; RISK-TAKING; SOCIAL SUPPORT; URBAN POPULATION;

EID: 84884127810     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073269     Document Type: Article

References (54)

1. Auvert B, Males S, Puren A, Taljaard D, Carael M, et al. (2004) Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa. J Acquir Immune Defic Syndr 36: 613-621.
2. New York City Department of Health and Mental Hygiene (2009) HIV Epidemiology and Field Services Program HIV epidemiology and field services report, October 2009.
3. Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN, (2011) Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep 8: 62-72.
4. Granich RM, Gilks C, Dye C, De Cock KM, Williams BG, (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet 373: 48-57.
5. El-Sadr WM, Mayer KH, Adimora AA, (2010) The HIV epidemic in the United States: a time for action. Introduction. J Acquir Immune Defic Syndr 55Suppl 2: S63.
6. Mermin J (2011) Conference on Retroviruses and Opportunistic Infections (CROI) 2011 Plenary session: The science of HIV prevention.
7. Cohen DA, Wu SY, Farley TA, (2004) Comparing the cost-effectiveness of HIV prevention interventions. J Acquir Immune Defic Syndr 37: 1404-1414.
8. Lasry A, Sansom SL, Hicks KA, Uzunangelov V, (2011) A model for allocating CDC's HIV prevention resources in the United States. Health Care Manag Sci 14: 115-124.
9. Marcus R, Culver DH, Bell DM, Srivastava PU, Mendelson MH, et al. (1993) Risk of human immunodeficiency virus infection among emergency department workers. Am J Med 94: 363-370.
10. Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, et al. (2006) The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 44: 990-997.
11. Markowitz H, (1952) Portfolio selection. Journal of Finance 7: 77-91.
12. Gold MR, Siegel JE, Russell LB, Weinstein MC, editors (2006) Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press.
13. Braithwaite RS, Nucifora KA, Yiannoutsos CT, Musick B, Kimaiyo S, et al. (2011) Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives? J Int AIDS Soc 14: 38.
14. Braithwaite RS, Justice AC, Chang CC, Fusco JS, Raffanti SR, et al. (2005) Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med 118: 890-898.
15. Braithwaite R, Roberts M, Justice A, (2007) Incorporating quality of evidence into decision analytic modeling. Annals of Internal Medicine 146: 133-141.
16. New York City Department of Mental Health and Hygiene (2009) Vital statistics.
17. Adimora AA, Schoenbach VJ, Doherty IA, (2007) Concurrent sexual partnerships among men in the United States. American Journal of Public Health 97: 2230-2237.
18. Buchacz K, Armon C, Palella FJ, Baker RK, Tedaldi E, et al. (2012) CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000-2009. AIDS research and treatment 2012: 869841.
19. Zhang J, Yu K, (1998) What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280: 1690-1691.
20. Department of Health and Human Services (2012) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Panel on Antiretroviral Guidelines for Adults and Adolescents.
21. Lasry A, Sansom SL, Hicks KA, Uzunangelov V, (2012) Allocating HIV Prevention Funds in the United States: Recommendations from an Optimization Model. PLoS One 7: e37545.
22. Walensky RP, Paltiel AD, Losina E, Morris BL, Scott CA, et al. (2010) Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. Clin Infect Dis 51: 392-400.
23. Paltiel AD, Walensky RP, Schackman BR, Seage GR 3rd, Mercincavage LM, et al. (2006) Expanded HIV screening in the United States: Effect on clinical outcomes, HIV transmission, and costs. Annals of Internal Medicine 145: 797-806.
24. Long EF, Brandeau ML, Owens DK, (2010) The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States. Ann Intern Med 153: 778-789.
25. Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, del Rio C, et al. (2005) Antiretroviral Treatment and Access Study Study Group. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS 19: 423-431.
26. Charania MR, Crepaz N, Guenther-Gray C, Henny K, Liau A, et al. (2010) Efficacy of Structural-Level Condom Distribution Interventions: A Meta-Analysis of U.S. and International Studies, 1998-2007. AIDS and Behavior 15: 1283-1297.
27. Anaya HD, Hoang T, Golden JF, Goetz MB, Gifford A, et al. (2008) Improving HIV screening and receipt of results by nurse-initiated streamlined counseling and rapid testing. Journal of General Internal Medicine 23: 800-807.
28. Calderon Y, Cowan E, Nickerson J, Mathew S, Fettig J, et al. (2011) Educational effectiveness of an HIV pretest video for adolescents: A randomized controlled trial. Pediatrics 127: 911-916.
29. Mullins TL, Kollar LM, Lehmann C, Kahn JA, (2010) Changes in human immunodeficiency virus testing rates among urban adolescents after introduction of routine and rapid testing. Arch Pediatr Adolesc Med 164: 870-874.
30. Rhodes SD, Vissman AT, Stowers J, Miller C, McCoy TP, et al. (2011) A CBPR partnership increases HIV testing among men who have sex with men (MSM): outcome findings from a pilot test of the CyBER/testing internet intervention. Health education & behavior: the official publication of the Society for Public Health Education 38: 311-320.
31. Wilton L, Herbst JH, Coury-Doniger P, Painter TM, English G, et al. (2009) Efficacy of an HIV/STI prevention intervention for black men who have sex with men: findings from the Many Men, Many Voices (3MV) project. AIDS and behavior 13: 532-544.
32. Barash EA, Golden M, (2010) Awareness and use of HIV pre-exposure prophylaxis among attendees of a Seattle gay pride event and sexually transmitted disease clinic. AIDS Patient Care and STDs 24: 689-691.
33. Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, del Rio C, et al. (2005) Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS and Behavior 19: 423-431.
34. Hart JE, Jeon CY, Ivers LC, Behforouz HL, Caldas A, et al. (2010) Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review. J Acquir Immune Defic Syndr 54: 167-179.
35. Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N, (2006) Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. J Acquir Immune Defic Syndr 43: S23-35.
36. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, et al. (1995) Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 346: 530-536.
37. Bertholet N, Daeppen JB, Wietlisbach V, Fleming M, Burnand B, (2005) Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis. Arch Intern Med 165: 986-995.
38. Hogben M, McNally T, McPheeters M, Hutchinson AB, (2007) The effectiveness of HIV partner counseling and referral services in increasing identification of HIV-positive individuals a systematic review. American Journal of Preventive Medicine 33: S89-100.
39. Latkin CA, Sherman S, Knowlton A, (2003) HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention. Health Psychology 22: 332-339.
40. Robles RR, Reyes JC, Colon HM, Sahai H, Marrero CA, et al. (2004) Effects of combined counseling and case management to reduce HIV risk behaviors among Hispanic drug injectors in Puerto Rico: A randomized controlled study. J Subst Abuse Treat 27: 145-152.
41. Vissers DC, De Vlas SJ, Bakker R, Urassa M, Voeten HA, et al. (2011) The impact of mobility on HIV control: A modelling study. Epidemiol Infect: 1-9.
42. New York City Department of Health and Mental Hygiene (2009) New York City HIV/AIDS annual surveillance statistics. New York.
43. New York City Department of Health and Mental Hygiene (2009) Community Health Survey.
44. Brady JE, Friedman SR, Cooper HL, Flom PL, Tempalski B, et al. (2008) Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. Journal of urban health: bulletin of the New York Academy of Medicine 85: 323-351.
45. New York City Department of Health and Mental Hygiene (2009) HIV Risk and Prevalence among New York City Injection Drug Users.
46. Jin F, Jansson J, Law M, Prestage GP, Zablotska I, et al. (2010) Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 24: 907-913.
47. Baggaley RF, White RG, Boily MC, (2010) HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. International journal of epidemiology 39: 1048-1063.
48. Boily MC, Baggaley RF, Wang L, Masse B, White RG, et al. (2009) Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. The Lancet infectious diseases 9: 118-129.
49. Tokars JI, Marcus R, Culver DH, Schable CA, McKibben PS, et al. (1993) Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group. Ann Intern Med 118: 913-919.
50. Attia S, Egger M, Muller M, Zwahlen M, Low N, (2009) Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 23: 1397-1404.
51. Mosher WD, Chandra A, Jones J (2005) Sexual Behavior and Selected Health Measures: Men and Women 15-44 Years of Age, United States, 2002. Advance Data 362.
52. Blower S, Ma L, Farmer P, Koenig S, (2003) Predicting the impact of antiretrovirals in resource-poor settings: preventing HIV infections whilst controlling drug resistance. Curr Drug Targets Infect Disord 3: 345-353.
53. Benedetti J, Corey L, Ashley R, (1994) Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 121: 847-854.
54. Wunsch-Hitzig R, Engstrom M, Lee R, King C, McVeigh K (2003) Prevalence and Cost Estimates of Psychiatric and Substance Use Disorders and Mental Retardation and Developmental Disabilities in NYC. New York: New York City Department of Health and Mental Hygiene.